{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:01:50Z","timestamp":1789153310618,"version":"build-2803163510"},"reference-count":75,"publisher":"American Society of Hematology","issue":"3","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,13]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Advancements in orally bioavailable iron chelators and MRI methods have improved life expectancy and reproductive potential in thalassemia major (TM) and thalassemia intermedia (TI). Pregnancy is associated with adverse maternal and neonatal outcomes, frequency of which has not been well delineated. This systematic review aims to provide risk estimates of maternal and fetal outcomes in TM and TI and explore pregnancy's impact on iron homeostasis. Fifteen studies (429 participants, 684 pregnancies) were included. Meta-analysis revealed a higher thrombosis risk in TI (3.7%) compared to TM (0.92%), unchanged from prepregnancy. Heart failure risks in the earlier years appeared similar (TM 1.6% vs TI 1.1%), and maternal mortality in TM was 3.7%, but with current management, these risks are rare. Gestational diabetes and pre-eclampsia occurred in 3.9% and 11.3% of TM pregnancies, respectively. Caesarean section rates were 83.9% in TM and 67% in TI. No significant difference in stillbirth, small for gestational age neonates, or preterm birth incidence between TM and TI was observed. In TM pregnancies, red cell requirements significantly increased (from 102 to 139 ml\/kg\/year, P = 0.001), and 70% of TI pregnancies required blood transfusions. As expected, increased transfusion alongside chelation cessation led to a significant increase in serum ferritin during pregnancy (TM by 1005\u00a0ng\/mL; TI by 332 ng\/mL, P &amp;lt; 0.0001). Deterioration in iron status was further reflected by an increase in liver iron concentration (from 4.6 to 11.9 mg\/g dry weight, P &amp;lt; 0.0001), and myocardial T2-star (T2\u2217) magnetic resonance imaging decreased (from 36.2 \u00b1 2.5 ms to 31.1\u00a0ms) during pregnancy. These findings emphasize the elevated maternal risk of iron-related cardiomyopathy during pregnancy and labor, stressing the importance of cardiac monitoring and postpartum chelation therapy resumption.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011636","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T23:27:26Z","timestamp":1704497246000},"page":"746-757","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Pregnancy outcomes and iron status in \u03b2-thalassemia major and intermedia: a systematic review and meta-analysis"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4330-6862","authenticated-orcid":false,"given":"Evangelia","family":"Vlachodimitropoulou","sequence":"first","affiliation":[{"name":"1Division of Maternal-Fetal Medicine, Mount Sinai Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2941-750X","authenticated-orcid":false,"given":"Hussain","family":"Mogharbel","sequence":"additional","affiliation":[{"name":"1Division of Maternal-Fetal Medicine, Mount Sinai Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-9238","authenticated-orcid":false,"given":"Kevin H. M.","family":"Kuo","sequence":"additional","affiliation":[{"name":"2Division of Haematology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-6856","authenticated-orcid":false,"given":"Michelle","family":"Hwang","sequence":"additional","affiliation":[{"name":"3Sidney Liswood Health Sciences Library, Mount Sinai Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-8603","authenticated-orcid":false,"given":"Richard","family":"Ward","sequence":"additional","affiliation":[{"name":"2Division of Haematology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-6256","authenticated-orcid":false,"given":"Nadine","family":"Shehata","sequence":"additional","affiliation":[{"name":"4Departments of Medicine and Laboratory Medicine and Pathobiology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3466-7570","authenticated-orcid":false,"given":"Ann Kinga","family":"Malinowski","sequence":"additional","affiliation":[{"name":"1Division of Maternal-Fetal Medicine, Mount Sinai Hospital, Toronto, ON, Canada"},{"name":"5Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada"},{"name":"6Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"2024021217145453000_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-5-11","article-title":"Beta-thalassemia","volume":"5","author":"Galanello","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2024021217145453000_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOH.0b013e32835f5a5c","article-title":"Iron overload in \u03b2-thalassemia intermedia: an emerging concern","volume":"20","author":"Musallam","year":"2013","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"2024021217145453000_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","article-title":"Iron overload in thalassemia: different organs at different rates","volume":"2017","author":"Taher","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2024021217145453000_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1196\/annals.1345.062","article-title":"Fertility and pregnancy in thalassemia major","volume":"1054","author":"Tuck","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"2024021217145453000_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/gim.2016.173","article-title":"\u03b2-Thalassemia","volume":"19","author":"Origa","year":"2017","journal-title":"Genet Med"},{"issue":"2 Pt 1","key":"2024021217145453000_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9378(99)70214-0","article-title":"Pregnancy in patients with well-treated beta-thalassemia: outcome for mothers and newborn infants","volume":"180","author":"Aessopos","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"2024021217145453000_bib7","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.3109\/03630260903365023","article-title":"Current perspectives of fertility and pregnancy in thalassemia","volume":"33","author":"Bajoria","year":"2009","journal-title":"Hemoglobin"},{"issue":"6","key":"2024021217145453000_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00277-017-2979-9","article-title":"Pregnancy in patients with thalassemia major: a cohort study and conclusions for an adequate care management approach","volume":"96","author":"Cassinerio","year":"2017","journal-title":"Ann Hematol"},{"issue":"9","key":"2024021217145453000_bib9","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1471-0528.1998.tb10270.x","article-title":"Pregnancy and homozygous beta thalassaemia major","volume":"105","author":"Daskalakis","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"2024021217145453000_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12185-016-1945-y","article-title":"Iron chelation therapy of transfusion-dependent \u03b2-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?","volume":"103","author":"Diamantidis","year":"2016","journal-title":"Int J Hematol"},{"issue":"3","key":"2024021217145453000_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000480450","article-title":"Pregnancy outcome among women with beta-thalassemia major in North Sardinia","volume":"138","author":"Fozza","year":"2017","journal-title":"Acta Haematol"},{"issue":"Suppl 3","key":"2024021217145453000_bib12","first-page":"945","article-title":"Fertility in thalassemia: the Greek experience","volume":"11","author":"Karagiorga-Lagana","year":"1998","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"3","key":"2024021217145453000_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijgo.2008.10.012","article-title":"Outcomes of pregnancies complicated by beta-thalassemia\/hemoglobin E disease","volume":"104","author":"Luewan","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"2024021217145453000_bib14","first-page":"628","article-title":"Outcome and management of pregnancy in women with thalassaemia in Cyprus","volume":"14","author":"Toumba","year":"2008","journal-title":"East Mediterr Health J"},{"issue":"4","key":"2024021217145453000_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/01443615.2017.1342616","article-title":"Pregnancy and iron status in \u03b2-thalassaemia major and intermedia: six years' experience in a North London Hospital","volume":"38","author":"Vlachodimitropoulou","year":"2018","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"9","key":"2024021217145453000_bib16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol"},{"issue":"15","key":"2024021217145453000_bib17","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"2024021217145453000_bib18","unstructured":"The Joanna Briggs Institute\n          . The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews. Checklist for Case Series. 2017. Accessed 1 March 2023. https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Case_Series2017_0.pdf."},{"key":"2024021217145453000_bib19","unstructured":"Wells\n              GA\n            , SheaB, O'ConnellD, . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2021. Accessed 16 May 2023. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"2024021217145453000_bib20","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"7414","key":"2024021217145453000_bib21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"2024021217145453000_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2141.2008.07155.x","article-title":"Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy","volume":"142","author":"Westerman","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"2024021217145453000_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy","volume":"16","author":"Bremme","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"issue":"10","key":"2024021217145453000_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1160\/TH06-05-0267","article-title":"Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran","volume":"96","author":"Taher","year":"2006","journal-title":"Thromb Haemost"},{"issue":"2","key":"2024021217145453000_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000040814","article-title":"Thromboembolic events in beta thalassemia major: an Italian multicenter study","volume":"99","author":"Borgna Pignatti","year":"1998","journal-title":"Acta Haematol"},{"issue":"22","key":"2024021217145453000_bib26","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"2024021217145453000_bib27","author":"RCOG","year":"2014"},{"issue":"5 Pt 1","key":"2024021217145453000_bib28","first-page":"730","article-title":"Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy","volume":"94","author":"Gherman","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2024021217145453000_bib29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/aogs.12223","article-title":"Venous thromboembolism in pregnancy and the puerperal period: a study of 1210 events","volume":"92","author":"Virkus","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"2024021217145453000_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.blre.2008.04.001","article-title":"Thalassemia and hypercoagulability","volume":"22","author":"Taher","year":"2008","journal-title":"Blood Rev"},{"issue":"1","key":"2024021217145453000_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/asheducation-2007.1.74","article-title":"Coagulation in the pathophysiology of hemolytic anemias","volume":"2007","author":"Cappellini","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"2024021217145453000_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2141.1993.tb04671.x","article-title":"Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II","volume":"83","author":"Porter","year":"1993","journal-title":"Br J Haematol"},{"issue":"1","key":"2024021217145453000_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2141.1995.tb03381.x","article-title":"Low plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusion","volume":"90","author":"O'Driscoll","year":"1995","journal-title":"Br J Haematol"},{"issue":"6","key":"2024021217145453000_bib34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1538-7836.2006.01912.x","article-title":"Beta-thalassemia intermedia and pregnancy: should we anticoagulate?","volume":"4","author":"Nassar","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2024021217145453000_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2141.2007.06654.x","article-title":"Modern treatment of thalassaemia intermedia","volume":"138","author":"Borgna-Pignatti","year":"2007","journal-title":"Br J Haematol"},{"issue":"10","key":"2024021217145453000_bib36","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3324\/haematol.13152","article-title":"Pregnancy outcome in patients with beta-thalassemia intermedia at two tertiary care centers, in Beirut and Milan","volume":"93","author":"Nassar","year":"2008","journal-title":"Haematologica"},{"key":"2024021217145453000_bib37","author":"L","year":"2005"},{"issue":"14","key":"2024021217145453000_bib38","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1311485","article-title":"Risk of a thrombotic event after the 6-week postpartum period","volume":"370","author":"Kamel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"2024021217145453000_bib39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"4","key":"2024021217145453000_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006254-199904000-00023","article-title":"Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation","volume":"54","author":"Ray","year":"1999","journal-title":"Obstet Gynecol Surv"},{"issue":"5","key":"2024021217145453000_bib41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A\u00a0population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"issue":"1","key":"2024021217145453000_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/adc.63.1.58","article-title":"Insulin dependent diabetes in thalassaemia","volume":"63","author":"De Sanctis","year":"1988","journal-title":"Arch Dis Child"},{"issue":"4","key":"2024021217145453000_bib43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/1573399811309040005","article-title":"Iron overload and glucose metabolism in subjects with \u03b2-thalassaemia major: an overview","volume":"9","author":"De Sanctis","year":"2013","journal-title":"Curr Diabetes Rev"},{"key":"2024021217145453000_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2017.03.030","article-title":"Prevalence of gestational diabetes mellitus in Europe: a meta-analysis","volume":"129","author":"Eades","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2024021217145453000_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"2024021217145453000_bib46","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/1076029617692879","article-title":"Soluble fms-like tyrosine kinase 1 as a link between angiogenesis and endothelial dysfunction in pediatric patients with \u03b2-thalassemia intermedia","volume":"23","author":"Tantawy","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"2024021217145453000_bib47","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/HYPERTENSIONAHA.117.09548","article-title":"Activating transcription factor 3 is reduced in preeclamptic placentas and negatively regulates sFlt-1 (soluble fms-Like tyrosine kinase 1), soluble endoglin, and proinflammatory cytokines in placenta","volume":"70","author":"Kaitu'u-Lino","year":"2017","journal-title":"Hypertension"},{"key":"2024021217145453000_bib48","doi-asserted-by":"crossref","first-page":"100175","DOI":"10.1016\/j.eurox.2022.100175","article-title":"Increased risk of eclampsia and preeclampsia during delivery hospitalizations in women with beta-thalassemia; an analysis of the National Inpatient Sample database","volume":"17","author":"Ammad Ud Din","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"issue":"6","key":"2024021217145453000_bib49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/ejh.13061","article-title":"PlGF and sFlt-1 levels in patients with non-transfusion-dependent thalassemia: correlations with markers of iron burden and endothelial dysfunction","volume":"100","author":"Kelaidi","year":"2018","journal-title":"Eur J Haematol"},{"issue":"4","key":"2024021217145453000_bib50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2024021217145453000_bib51","author":"World Health Organization","year":"2021"},{"key":"2024021217145453000_bib52","author":"BORN Ontario","year":"2022"},{"issue":"3","key":"2024021217145453000_bib53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3324\/haematol.2009.012393","article-title":"Pregnancy and beta-thalassemia: an Italian multicenter experience","volume":"95","author":"Origa","year":"2010","journal-title":"Haematologica"},{"key":"2024021217145453000_bib54","author":"Osuchukwu","year":"2023"},{"key":"2024021217145453000_bib55","author":"World Health Organization","year":"2023"},{"issue":"4","key":"2024021217145453000_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00000542-196507000-00004","article-title":"Changes in the blood volume during pregnancy and delivery","volume":"26","author":"Pritchard","year":"1965","journal-title":"Anesthesiology"},{"issue":"3","key":"2024021217145453000_bib57","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0002-9378(72)90493-0","article-title":"Plasma and red cell volumes during pregnancy","volume":"112","author":"Chesley","year":"1972","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2024021217145453000_bib58","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy","volume":"130","author":"Sanghavi","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"2024021217145453000_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0609.2004.00304.x","article-title":"Cardiac status in well-treated patients with thalassemia major","volume":"73","author":"Aessopos","year":"2004","journal-title":"Eur J Haematol"},{"issue":"11","key":"2024021217145453000_bib60","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V97.11.3411","article-title":"Cardiac involvement in thalassemia intermedia: a multicenter study","volume":"97","author":"Aessopos","year":"2001","journal-title":"Blood"},{"issue":"5","key":"2024021217145453000_bib61","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1378\/chest.127.5.1523","article-title":"Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia","volume":"127","author":"Aessopos","year":"2005","journal-title":"Chest"},{"issue":"1","key":"2024021217145453000_bib62","doi-asserted-by":"crossref","first-page":"e004005","DOI":"10.1161\/CIRCHEARTFAILURE.117.004005","article-title":"Heart failure in pregnant women: a concern across the pregnancy continuum","volume":"11","author":"Mogos","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"3","key":"2024021217145453000_bib63","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2\u2217 cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"issue":"10","key":"2024021217145453000_bib64","first-page":"1388","article-title":"Multi-center validation of the transferability of the magnetic resonance T2\u2217 technique for the quantification of tissue iron","volume":"91","author":"Tanner","year":"2006","journal-title":"Haematologica"},{"issue":"6","key":"2024021217145453000_bib65","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0002-9378(83)90457-X","article-title":"Iron overdose during pregnancy: successful therapy with deferoxamine","volume":"147","author":"Rayburn","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"3 Suppl","key":"2024021217145453000_bib66","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/00006250-198409001-00003","article-title":"Deferoxamine treatment of acute iron intoxication in pregnancy","volume":"64","author":"Blanc","year":"1984","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2024021217145453000_bib67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/096032719101000404","article-title":"The consequences of iron overdose and its treatment with desferrioxamine in pregnancy","volume":"10","author":"McElhatton","year":"1991","journal-title":"Hum Exp Toxicol"},{"issue":"5","key":"2024021217145453000_bib68","first-page":"441","article-title":"Successful therapy of iron intoxication in pregnancy with intravenous deferoxamine and whole bowel irrigation","volume":"35","author":"Turk","year":"1993","journal-title":"Vet Hum Toxicol"},{"issue":"7","key":"2024021217145453000_bib69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s002040050200","article-title":"Assessment of the developmental toxicity of deferoxamine in mice","volume":"69","author":"Bosque","year":"1995","journal-title":"Arch Toxicol"},{"issue":"9","key":"2024021217145453000_bib70","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3109\/00016349509021190","article-title":"Deferoxamine treatment for acute iron intoxication in pregnancy","volume":"74","author":"Khoury","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2024021217145453000_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tjog.2019.11.018","article-title":"Use of deferoxamine (DFO) in transfusion-dependent \u03b2-thalassemia during pregnancy: a retrospective study","volume":"59","author":"Piccioni","year":"2020","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"2024021217145453000_bib72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2004.08.005","article-title":"Impairment of cardiac function in a successful full-term pregnancy in a homozygous beta-thalassemia major: does chelation have a positive role?","volume":"120","author":"Tsironi","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2024021217145453000_bib73","first-page":"183","article-title":"Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases","volume":"78","author":"Vaskaridou","year":"1993","journal-title":"Haematologica"},{"key":"2024021217145453000_bib74","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1196\/annals.1345.047","article-title":"Physiology and pathophysiology of iron cardiomyopathy in thalassemia","volume":"1054","author":"Wood","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2024021217145453000_bib75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1471-0528.1999.tb08091.x","article-title":"Pregnancy and homozygous beta thalassemia major","volume":"106","author":"Surbek","year":"1999","journal-title":"Br J Obstet Gynaecol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/3\/746\/2212958\/blooda_adv-2023-011636-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/3\/746\/2212958\/blooda_adv-2023-011636-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T17:15:49Z","timestamp":1707758149000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/3\/746\/506968\/Pregnancy-outcomes-and-iron-status-in-thalassemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011636","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}